Nifty

:

23587.50

Sensex

:

78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Login

Nifty
Sensex

:
:

23587.50
78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Caplin Point Laboratories Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 524742 | NSE: CAPLIPOINT

Watchlist

NSE BSE

2311.45

20-Dec-2024

Open
High
Low
Previous Close

2393.00
2408.00
2292.50
2393.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

69711
1641.67
2539.85
1225.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

17,566.68
35.59
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

17,033.10
0.22%
6.91

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
14.44
10.10

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
16.22
6.93

PAT CAGR (%)

10 Years
5 Years
3 Years

-
16.28
15.09

P:E (Median)

8 Years
5 Years
3 Years

19.88
18.80
20.10

P:BV (Average)

8 Years
5 Years
3 Years

6.79
4.09
4.26

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.52
13.22
14.46

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 60.19 69.97 76.42 93.02
P/E Ratio 34.6 29.76 27.25 22.39
Revenue 1694 1949 2220 2560
EBITDA 551 646 743 865
Net Income 457 514 580 706
ROA 18.7 22.1 20.8 21.1
P/Bk Ratio 7.06 5.75 4.69 4.11
ROE 22.59 20.1 18.6 18.7
FCFF 215.52 324.9 418.99 504.05
FCFF Yield 1.4 2.11 2.72 3.28

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 207.93 179.22 16.02% 185.64 173.66 6.90% 139.38 144.67 -3.66% 132.83 130.60 1.71%
Expenses 109.77 89.77 22.28% 104.26 97.04 7.44% 81.70 79.80 2.38% 69.51 79.09 -12.11%
EBITDA 98.16 89.45 9.74% 81.38 76.62 6.21% 57.68 64.87 -11.08% 63.32 51.51 22.93%
EBIDTM 47.21% 49.91% 43.84% 44.12% 41.38% 44.84% 47.67% 39.44%
Other Income 43.01 24.49 75.62% 21.50 27.27 -21.16% 36.18 12.22 196.07% 17.90 29.36 -39.03%
Interest 0.02 0.02 0.00% 0.02 0.03 -33.33% 0.02 0.03 -33.33% 0.03 0.04 -25.00%
Depreciation 6.49 6.72 -3.42% 6.18 6.67 -7.35% 6.93 6.29 10.17% 6.76 6.47 4.48%
PBT 134.66 107.20 25.62% 96.68 97.19 -0.52% 86.91 70.77 22.81% 74.43 74.36 0.09%
Tax 28.92 25.10 15.22% 24.14 20.92 15.39% 17.03 16.44 3.59% 18.98 15.19 24.95%
PAT 105.74 82.10 28.79% 72.54 76.27 -4.89% 69.88 54.33 28.62% 55.45 59.17 -6.29%
PATM 50.85% 45.81% 39.08% 43.92% 50.14% 37.55% 41.75% 45.31%
EPS 13.91 10.80 28.80% 9.54 10.04 -4.98% 9.19 7.15 28.53% 7.30 7.79 -6.29%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 483.10 410.06 17.81% 458.96 395.32 16.10% 453.22 389.28 16.43% 435.50 372.07 17.05%
Expenses 318.34 272.66 16.75% 307.15 268.79 14.27% 307.99 265.35 16.07% 293.22 262.70 11.62%
EBITDA 164.76 137.40 19.91% 151.81 126.53 19.98% 145.23 123.93 17.19% 142.28 109.37 30.09%
EBIDTM 34.10% 33.51% 33.08% 32.01% 32.04% 31.84% 32.67% 29.39%
Other Income 20.77 20.43 1.66% 18.56 12.04 54.15% 17.29 11.40 51.67% 17.18 14.15 21.41%
Interest 0.21 0.18 16.67% 0.05 0.28 -82.14% 0.15 0.23 -34.78% 0.17 0.36 -52.78%
Depreciation 16.76 11.76 42.52% 15.96 11.38 40.25% 16.40 11.13 47.35% 13.90 11.43 21.61%
PBT 168.56 145.89 15.54% 154.36 126.91 21.63% 145.97 123.97 17.75% 145.39 111.73 30.13%
Tax 37.65 29.86 26.09% 29.46 22.76 29.44% 24.80 22.81 8.72% 25.59 14.35 78.33%
PAT 130.91 116.03 12.82% 124.90 104.15 19.92% 121.17 101.16 19.78% 119.80 97.38 23.02%
PATM 27.10% 28.30% 27.21% 26.35% 26.74% 25.99% 27.51% 26.17%
EPS 17.21 15.12 13.82% 16.31 13.62 19.75% 16.01 13.45 19.03% 15.43 12.84 20.17%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Net Sales 665.78 625.09 528.61 528.06 482.68 527.83 536.91 426.57 341.55 231.29 240.23 Net Sales Growth 5.99% 18.25% 0.10% 9.40% -8.55% -1.69% 25.87% 24.89% 47.67% -3.72% Cost Of Goods Sold 207.20 205.22 198.06 204.65 194.83 238.18 237.03 180.11 161.94 116.73 128.25 Gross Profit 458.58 419.87 330.55 323.41 287.85 289.65 299.87 246.46 179.61 114.56 111.98 GP Margin 68.88% 67.17% 62.53% 61.24% 59.64% 54.88% 55.85% 57.78% 52.59% 49.53% 46.61% Total Expenditure 365.24 338.01 309.23 308.58 273.14 320.83 348.31 284.33 247.72 168.78 183.03 Power & Fuel Cost - 15.43 9.89 9.54 6.36 7.19 12.29 10.96 9.85 7.55 8.39 % Of Sales - 2.47% 1.87% 1.81% 1.32% 1.36% 2.29% 2.57% 2.88% 3.26% 3.49% Employee Cost - 37.18 35.81 29.91 26.03 24.39 40.49 37.29 29.48 17.58 17.84 % Of Sales - 5.95% 6.77% 5.66% 5.39% 4.62% 7.54% 8.74% 8.63% 7.60% 7.43% Manufacturing Exp. - 54.17 42.18 34.68 27.15 33.34 38.72 37.02 28.34 13.84 15.59 % Of Sales - 8.67% 7.98% 6.57% 5.62% 6.32% 7.21% 8.68% 8.30% 5.98% 6.49% General & Admin Exp. - 18.24 13.52 12.55 6.50 8.55 14.96 12.18 12.63 7.60 7.43 % Of Sales - 2.92% 2.56% 2.38% 1.35% 1.62% 2.79% 2.86% 3.70% 3.29% 3.09% Selling & Distn. Exp. - 1.88 3.91 12.23 2.78 5.89 2.64 4.74 5.37 2.11 2.62 % Of Sales - 0.30% 0.74% 2.32% 0.58% 1.12% 0.49% 1.11% 1.57% 0.91% 1.09% Miscellaneous Exp. - 5.89 5.86 5.02 9.49 3.29 2.17 2.03 0.11 3.38 2.62 % Of Sales - 0.94% 1.11% 0.95% 1.97% 0.62% 0.40% 0.48% 0.03% 1.46% 1.21% EBITDA 300.54 287.08 219.38 219.48 209.54 207.00 188.60 142.24 93.83 62.51 57.20 EBITDA Margin 45.14% 45.93% 41.50% 41.56% 43.41% 39.22% 35.13% 33.35% 27.47% 27.03% 23.81% Other Income 118.59 105.84 99.54 56.69 23.01 65.97 35.40 23.31 12.51 3.47 2.74 Interest 0.09 0.10 0.12 0.09 0.17 0.19 0.50 0.52 0.50 0.31 0.87 Depreciation 26.36 27.08 25.65 25.77 22.44 19.65 20.84 18.99 13.26 7.30 8.28 PBT 392.68 365.74 293.15 250.31 209.94 253.12 202.65 146.05 92.58 58.38 50.80 Tax 89.07 82.03 58.89 62.44 53.71 55.49 54.49 43.74 22.26 13.05 9.86 Tax Rate 22.68% 22.43% 20.09% 24.95% 25.58% 21.92% 26.89% 29.95% 24.04% 22.35% 19.41% PAT 303.61 283.71 234.26 187.87 156.23 197.64 148.17 102.31 70.32 45.33 40.94 PAT before Minority Interest 303.61 283.71 234.26 187.87 156.23 197.64 148.17 102.31 70.32 45.33 40.94 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 45.60% 45.39% 44.32% 35.58% 32.37% 37.44% 27.60% 23.98% 20.59% 19.60% 17.04% PAT Growth 11.67% 21.11% 24.69% 20.25% -20.95% 33.39% 44.82% 45.49% 55.13% 10.72% EPS 39.95 37.33 30.82 24.72 20.56 26.01 19.50 13.46 9.25 5.96 5.39

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Net Sales 1,830.78 1,694.10 1,466.73 1,269.41 1,061.29 863.20 648.69 539.84 401.65 238.72 251.77 Net Sales Growth 16.85% 15.50% 15.54% 19.61% 22.95% 33.07% 20.16% 34.41% 68.25% -5.18% Cost Of Goods Sold 755.78 724.18 663.21 557.51 471.74 413.16 288.78 238.18 184.93 121.16 135.62 Gross Profit 1,075.00 969.92 803.52 711.90 589.55 450.04 359.91 301.66 216.72 117.56 116.15 GP Margin 58.72% 57.25% 54.78% 56.08% 55.55% 52.14% 55.48% 55.88% 53.96% 49.25% 46.13% Total Expenditure 1,226.70 1,142.65 1,026.21 874.88 737.04 603.13 416.84 344.52 276.84 174.51 192.06 Power & Fuel Cost - 33.57 25.53 21.40 16.36 14.81 13.76 10.98 9.91 7.56 8.61 % Of Sales - 1.98% 1.74% 1.69% 1.54% 1.72% 2.12% 2.03% 2.47% 3.17% 3.42% Employee Cost - 142.66 136.12 114.74 101.97 67.15 45.58 37.61 29.71 17.92 18.24 % Of Sales - 8.42% 9.28% 9.04% 9.61% 7.78% 7.03% 6.97% 7.40% 7.51% 7.24% Manufacturing Exp. - 117.73 90.99 82.01 69.85 68.23 43.49 37.11 28.56 14.33 16.04 % Of Sales - 6.95% 6.20% 6.46% 6.58% 7.90% 6.70% 6.87% 7.11% 6.00% 6.37% General & Admin Exp. - 89.41 85.38 66.68 38.53 25.50 20.82 12.27 13.78 8.15 7.97 % Of Sales - 5.28% 5.82% 5.25% 3.63% 2.95% 3.21% 2.27% 3.43% 3.41% 3.17% Selling & Distn. Exp. - 28.44 18.78 27.52 18.03 9.95 2.08 5.92 9.41 2.29 2.85 % Of Sales - 1.68% 1.28% 2.17% 1.70% 1.15% 0.32% 1.10% 2.34% 0.96% 1.13% Miscellaneous Exp. - 6.66 6.20 5.02 20.56 4.33 2.33 2.45 0.55 3.10 2.85 % Of Sales - 0.39% 0.42% 0.40% 1.94% 0.50% 0.36% 0.45% 0.14% 1.30% 1.08% EBITDA 604.08 551.45 440.52 394.53 324.25 260.07 231.85 195.32 124.81 64.21 59.71 EBITDA Margin 33.00% 32.55% 30.03% 31.08% 30.55% 30.13% 35.74% 36.18% 31.07% 26.90% 23.72% Other Income 73.80 66.94 56.52 38.89 27.93 41.33 19.03 12.67 9.96 3.66 3.03 Interest 0.58 0.78 0.78 0.70 1.59 0.32 0.58 0.61 0.52 0.34 0.97 Depreciation 63.02 53.44 44.99 46.90 36.97 31.62 23.43 19.00 13.30 7.48 8.38 PBT 614.28 564.17 451.27 385.82 313.62 269.46 226.88 188.38 120.95 60.05 53.39 Tax 117.50 103.01 74.36 77.37 62.19 54.38 50.32 43.74 25.44 14.28 12.26 Tax Rate 19.13% 18.26% 16.48% 20.05% 19.83% 20.18% 22.18% 23.22% 21.03% 23.78% 22.96% PAT 496.78 457.09 376.26 299.84 242.27 215.00 176.56 144.78 95.61 45.77 41.04 PAT before Minority Interest 493.56 461.42 376.99 308.45 251.43 215.08 176.56 144.63 95.50 45.77 41.13 Minority Interest -3.22 -4.33 -0.73 -8.61 -9.16 -0.08 0.00 0.15 0.11 0.00 -0.09 PAT Margin 27.13% 26.98% 25.65% 23.62% 22.83% 24.91% 27.22% 26.82% 23.80% 19.17% 16.30% PAT Growth 18.64% 21.48% 25.49% 23.76% 12.68% 21.77% 21.95% 51.43% 108.89% 11.53% EPS 65.37 60.14 49.51 39.45 31.88 28.29 23.23 19.05 12.58 6.02 5.40

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Shareholder's Funds 1,390.15 1,139.91 930.65 758.67 599.91 432.04 295.60 200.12 128.14 93.63 Share Capital 15.19 15.18 15.16 15.13 15.13 15.13 15.12 15.12 15.11 15.11 Total Reserves 1,360.74 1,109.36 900.04 728.75 575.34 410.06 277.19 184.91 111.40 78.52 Non-Current Liabilities 12.86 16.42 24.63 24.99 27.16 24.77 27.86 19.90 13.69 10.39 Secured Loans 0.00 0.00 0.00 0.00 0.02 0.29 0.32 0.48 0.73 0.88 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.40 1.63 0.82 Current Liabilities 119.30 146.85 98.88 77.33 64.26 82.51 87.34 97.05 120.77 119.18 Trade Payables 78.62 70.63 65.02 70.11 51.41 59.50 72.89 66.01 51.47 38.04 Other Current Liabilities 36.26 65.26 32.66 6.06 11.97 21.76 13.86 29.37 60.37 71.36 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 Short Term Provisions 4.42 10.96 1.20 1.16 0.87 1.25 0.58 1.67 8.92 9.73 Total Liabilities 1,522.31 1,303.18 1,054.16 860.99 691.33 539.32 410.80 317.07 262.60 223.20 Net Block 165.79 156.85 162.46 182.68 166.93 137.77 169.32 151.75 142.75 111.47 Gross Block 318.45 285.13 268.64 266.22 228.35 179.85 231.63 195.07 178.70 140.64 Accumulated Depreciation 152.66 128.28 106.18 83.54 61.43 42.08 62.31 43.32 35.94 29.17 Non Current Assets 819.21 641.48 448.49 348.35 310.59 251.37 197.59 180.34 147.78 146.11 Capital Work in Progress 27.75 42.68 2.60 1.36 3.77 8.62 15.29 3.42 0.23 30.63 Non Current Investment 346.17 274.97 212.73 138.64 135.54 98.62 1.87 14.58 1.43 1.44 Long Term Loans & Adv. 272.07 164.70 70.70 5.67 4.36 6.36 11.11 10.59 3.37 2.57 Other Non Current Assets 7.43 2.28 0.00 20.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 703.10 661.70 605.67 512.64 380.74 287.95 213.21 136.73 114.82 77.10 Current Investments 237.98 210.18 51.97 10.54 60.23 69.62 46.34 4.20 0.00 0.00 Inventories 86.25 51.53 42.81 24.87 22.37 23.52 28.46 22.29 17.90 12.66 Sundry Debtors 128.67 88.24 53.73 98.46 218.98 125.39 86.35 3.21 6.80 0.02 Cash & Bank 215.78 271.38 316.08 345.49 58.27 44.85 28.28 76.66 64.77 40.32 Other Current Assets 34.42 2.17 11.97 18.31 20.89 24.56 23.78 30.37 25.35 24.10 Short Term Loans & Adv. 32.15 38.20 129.11 14.97 10.57 15.95 17.00 23.05 14.93 18.59 Net Current Assets 583.80 514.85 506.79 435.31 316.48 205.44 125.87 39.67 -5.95 -42.08 Total Assets 1,522.31 1,303.18 1,054.16 860.99 691.33 539.32 410.80 317.07 262.60 223.21

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Shareholder's Funds 2,315.71 1,880.48 1,483.93 1,185.83 947.91 632.91 363.83 224.76 128.14 93.19 Share Capital 89.77 89.76 89.74 89.71 89.71 51.05 15.12 15.12 15.11 15.11 Total Reserves 2,211.72 1,775.35 1,378.74 1,081.33 848.76 575.01 345.42 209.56 111.40 78.08 Non-Current Liabilities 7.46 2.13 12.55 17.39 24.86 23.42 27.86 19.90 13.69 10.39 Secured Loans 0.00 0.00 0.00 0.00 0.02 0.29 0.32 0.48 0.73 0.88 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 8.61 7.78 8.48 5.69 5.23 0.13 0.00 0.40 1.63 0.82 Current Liabilities 331.28 268.00 207.68 142.85 144.32 86.11 108.67 113.36 125.04 124.97 Trade Payables 209.41 152.56 155.94 88.50 64.14 60.47 94.23 78.60 55.71 41.56 Other Current Liabilities 110.50 99.94 48.68 51.87 79.28 24.20 13.86 33.09 60.39 72.11 Short Term Borrowings 0.28 3.41 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.05 Short Term Provisions 11.09 12.09 2.56 2.48 0.91 1.44 0.58 1.67 8.94 11.25 Total Liabilities 2,685.57 2,177.40 1,730.11 1,363.61 1,125.75 742.52 500.45 358.38 267.14 228.82 Net Block 452.66 279.81 286.57 305.34 272.50 226.84 169.48 151.83 144.23 113.13 Gross Block 702.31 480.32 445.74 422.58 354.79 271.51 231.79 195.15 180.76 142.71 Accumulated Depreciation 249.65 200.51 159.17 117.24 82.29 44.67 62.31 43.31 36.53 29.58 Non Current Assets 792.65 625.21 432.29 349.04 303.23 248.83 196.34 179.16 148.61 146.95 Capital Work in Progress 116.62 220.71 17.73 13.88 20.12 9.70 15.29 3.42 0.23 30.63 Non Current Investment 137.63 70.52 37.01 0.66 0.56 0.33 0.33 13.24 0.44 0.45 Long Term Loans & Adv. 78.31 51.51 89.90 7.92 10.05 11.95 11.23 10.67 3.71 2.75 Other Non Current Assets 7.43 2.66 1.08 21.24 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,892.92 1,552.19 1,297.82 1,014.57 822.53 493.69 304.11 179.22 118.53 81.87 Current Investments 237.98 210.18 51.97 10.54 60.23 69.62 46.34 4.20 0.00 0.00 Inventories 363.04 288.22 227.31 179.01 238.23 37.45 28.46 22.29 18.81 13.66 Sundry Debtors 542.72 394.06 317.05 279.36 228.96 159.81 125.88 33.02 7.95 5.66 Cash & Bank 552.74 493.48 462.99 438.33 223.43 152.99 79.28 93.07 68.10 45.37 Other Current Assets 196.44 22.82 13.61 20.25 71.68 73.83 24.16 26.63 23.67 17.18 Short Term Loans & Adv. 146.01 143.43 224.89 87.08 56.81 64.61 17.28 19.31 12.58 11.08 Net Current Assets 1,561.64 1,284.19 1,090.14 871.72 678.21 407.58 195.44 65.86 -6.51 -43.10 Total Assets 2,685.57 2,177.40 1,730.11 1,363.61 1,125.76 742.52 500.45 358.38 267.14 228.82

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Cash From Operating Activity 111.01 157.10 230.97 294.64 87.01 107.34 22.61 55.49 44.37 49.53 PBT 365.74 293.15 250.31 209.94 253.12 202.65 146.05 92.58 58.38 50.80 Adjustment -68.57 -59.57 -19.43 7.75 -32.58 -0.29 3.44 8.06 3.89 6.32 Changes in Working Capital -99.07 -11.45 62.07 131.85 -83.19 -54.17 -92.59 -24.76 -7.20 1.91 Cash after chg. in Working capital 198.10 222.13 292.95 349.54 137.36 148.19 56.90 75.88 55.07 59.03 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -87.09 -65.03 -61.98 -54.90 -50.35 -40.84 -34.29 -20.39 -10.69 -9.50 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -118.94 -86.67 -275.93 -3.71 -41.06 -76.51 -59.71 -37.07 -5.98 -23.76 Net Fixed Assets -18.39 -56.57 -3.66 -35.46 -43.65 58.45 -48.43 -19.56 -7.66 -25.72 Net Investments -99.00 -220.45 -115.52 46.59 -27.53 -120.03 -29.43 -17.35 0.01 -0.90 Others -1.55 190.35 -156.75 -14.84 30.12 -14.93 18.15 -0.16 1.67 2.86 Cash from Financing Activity -34.26 -30.42 -22.76 -3.47 -32.92 -15.21 -11.60 -6.74 -13.95 -8.62 Net Cash Inflow / Outflow -42.19 40.01 -67.72 287.46 13.03 15.62 -48.70 11.67 24.45 17.15 Opening Cash & Equivalents 122.02 81.01 148.82 55.61 42.52 26.18 74.89 63.22 40.32 23.17 Closing Cash & Equivalent 80.64 122.02 81.01 342.88 55.61 42.52 26.18 74.89 64.77 40.32

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Cash From Operating Activity 318.39 271.37 336.73 268.61 44.68 83.42 66.49 67.61 42.40 49.88 PBT 564.43 451.35 385.82 313.62 269.46 226.88 188.38 120.95 60.05 53.39 Adjustment 2.40 11.77 30.44 23.09 7.09 19.12 14.84 8.61 3.87 6.21 Changes in Working Capital -139.44 -103.75 1.96 -1.96 -177.11 -120.06 -100.38 -38.39 -5.13 1.96 Cash after chg. in Working capital 427.39 359.37 418.22 334.75 99.44 125.94 102.84 91.16 58.78 61.56 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -109.00 -88.00 -81.49 -66.14 -54.76 -42.51 -36.35 -23.55 -16.38 -11.67 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -320.04 -217.58 -376.77 -29.44 -54.50 -100.46 -69.02 -36.11 -5.72 -22.66 Net Fixed Assets -18.39 -56.57 -3.66 -35.46 -43.65 58.45 -48.43 -19.56 -7.66 -25.72 Net Investments -99.00 -220.45 -115.52 46.59 -27.53 -120.03 -29.43 -17.35 0.01 -0.90 Others -202.65 59.44 -257.59 -40.57 16.68 -38.88 8.84 0.80 1.93 3.96 Cash from Financing Activity -38.07 -28.17 -40.68 -23.98 79.77 89.79 -11.60 -6.74 -13.95 -8.67 Net Cash Inflow / Outflow -39.72 25.62 -80.72 215.19 69.94 72.76 -14.13 24.76 22.73 18.55 Opening Cash & Equivalents 177.56 150.76 231.57 220.77 150.65 77.17 91.31 66.55 45.37 26.82 Closing Cash & Equivalent 138.55 170.92 150.76 435.72 220.77 150.65 77.17 91.31 68.10 45.37

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Book Value (Rs.) 181.16 148.16 120.74 98.33 78.06 56.22 38.66 26.47 16.25 11.90 ROA 20.08% 19.87% 19.62% 20.13% 32.12% 31.19% 28.11% 24.26% 18.66% 20.60% ROE 22.69% 22.97% 22.65% 23.42% 38.92% 41.30% 41.56% 43.57% 42.62% 55.15% ROCE 28.92% 28.33% 29.64% 30.92% 49.05% 55.76% 58.99% 56.89% 53.75% 67.20% Fixed Asset Turnover 2.07 1.91 1.97 1.95 2.59 2.61 2.00 1.83 1.45 1.84 Receivable days 63.33 49.01 52.60 120.02 119.07 71.97 38.32 5.35 5.38 0.02 Inventory Days 40.23 32.57 23.39 17.86 15.87 17.67 21.71 21.48 24.11 15.55 Payable days 132.73 124.99 120.50 113.83 61.02 67.67 86.81 85.61 98.57 65.47 Cash Conversion Cycle -29.17 -43.41 -44.52 24.05 73.91 21.97 -26.78 -58.79 -69.08 -49.90 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 Interest Cover 3658.40 2443.92 2782.22 1235.94 1369.24 404.61 281.22 185.02 190.79 59.55

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Book Value (Rs.) 293.21 235.91 183.89 144.94 114.21 78.03 47.69 29.73 16.25 11.84 ROA 18.98% 19.30% 19.94% 20.20% 23.02% 28.41% 33.68% 30.54% 18.46% 20.12% ROE 22.97% 23.68% 24.77% 25.65% 29.58% 37.14% 49.43% 54.97% 43.13% 55.78% ROCE 26.92% 26.85% 28.77% 28.82% 33.35% 45.59% 64.08% 69.03% 55.41% 71.11% Fixed Asset Turnover 2.87 3.17 2.92 2.73 2.76 2.58 2.53 2.14 1.48 1.89 Receivable days 100.92 88.48 85.74 87.41 82.19 80.37 53.72 18.62 10.40 4.17 Inventory Days 70.16 64.15 58.42 71.75 58.28 18.54 17.16 18.68 24.83 17.00 Payable days 91.22 84.89 80.02 59.05 28.33 65.76 89.68 88.17 103.48 69.75 Cash Conversion Cycle 79.85 67.73 64.14 100.11 112.15 33.15 -18.80 -50.88 -68.24 -48.58 Total Debt/Equity 0.00 0.00 0.00 0.01 0.04 0.00 0.00 0.00 0.02 0.02 Interest Cover 724.63 579.65 552.17 198.25 843.86 391.22 309.72 235.08 179.35 56.11

Top Investors:

investor education and protection fund authority ministry of corporate affairs

uti small cap fund

Annual Reports:

News Update:

Caplin Point Laboratories’ arm gets USFDA’s approval for Difluprednate Ophthalmic Emulsion
16th Dec 2024, 12:48 PM

Difluprednate Ophthalmic Emulsion, 0.5% had US sales of approximately $21 million for the 12-month period ending October 2024
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback